SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-755496
Filing Date
2016-11-01
Accepted
2016-11-01 17:18:02
Documents
80
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d245336d10q.htm 10-Q 691444
2 EX-10.1 d245336dex101.htm EX-10.1 397495
3 EX-10.2 d245336dex102.htm EX-10.2 23623
4 EX-31.1 d245336dex311.htm EX-31.1 8761
5 EX-31.2 d245336dex312.htm EX-31.2 8723
6 EX-32.1 d245336dex321.htm EX-32.1 3794
  Complete submission text file 0001193125-16-755496.txt   4649020

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lnth-20160930.xml EX-101.INS 748228
8 XBRL TAXONOMY EXTENSION SCHEMA lnth-20160930.xsd EX-101.SCH 57033
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lnth-20160930_cal.xml EX-101.CAL 96638
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lnth-20160930_def.xml EX-101.DEF 164860
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lnth-20160930_lab.xml EX-101.LAB 421315
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lnth-20160930_pre.xml EX-101.PRE 292185
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 161965622
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences